a-c, Schematic drawing of the experimental design (top) and
representative images of cFos expressions (bottom) in DMT following handling
(a), habituation (no shock); b) and foot shock
(c).
d, Representative confocal image of the co-localization of cFos and
CR in DMT cells in a foot-shock case.
e, Left, Normalized data for cFos expressing DMT cells in Control
(C), Habituation (H) and Shock (Sh) situations (n= 4-4mice; control: 100
± 40%; habituation: 179 ± 24%, shock: 249 ± 12%; two-tailed
unpaired t-test, C vs. H, t(6) = -3,339, p = 0.0156; H vs. Sh,
t(6) = -5,152, p = 0.0021; C vs. Sh, t(6) = -7,043, p = 0.0004). Right,
CR-content (right) of cFos expressing cells in case of Sh. Yellow bar indicates
CR+/cFos+ cells (1393/1433 neurons, 97.2%; n=4 mice), green bar CR-/cFos+ cells
(40/1433, neurons, 2.8%).
f, Schematic drawing for optogenetic inhibition of DMT/CR+ in a
novel environment.
g-h, Representative data for short immobile states (red dots) evoked
by optogenetic silencing during the exploration of a novel box (grey) in a YFP
(control, g) and a SwichR-injected mouse (h).
i, Population data for the number of immobile states during the
pre-OFF (3 mins), ON (3 mins) and post-OFF (3 mins; see Methods) periods in the YFP (n = 6 mice; pre OFF n =
12.2± 3.0; ON period n = 11.2 ± 1.7, post OFF n = 9.3 ±
1.6) and SwichR-injected animals (n = 7 mice; pre OFF n = 18.9 ± 1.9; ON
period n = 29.9 ± 4.4, post OFF n = 23.3 ± 2.7). Repeated-measures
ANOVA with Fisher’s LSD, F(2, 22) = 3.4945, p = 0.0481. CM, centromedial
thalamic nucleus; IL, intralaminar thalamic nuclei; PVA, paraventricular
thalamic nucleus, anterior part. Bar graphs are means ± SD;
open circles in e and i represent data for single
animals; the horizontal lines in the box plots indicate medians, the box limits
indicate first and third quantiles, and the vertical whisker lines indicate
minimum and maximum values. *p < 0.05; **p < 0.01, ***p <
0.001.